Clinical characteristics and natural history of patients with cardiac amyloidosis in King Chulalongkorn Memorial Hospital: a 20-year review

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210801002

Enrollment

Registered

2021-08-01

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac amyloidosis in Thailand, focus on clinical manifestation and clinical outcomes. Cardiac amyloidosis Transthyretin ATTR AL cardiomyopathy Natural history Prognosis

Interventions

Cardiac amyloidosis patient in King chulalongkorn University who was diagnosed since 2000.

Other

Cardiac Amyloidosis patient

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients (age >/= 18 yeras) 2. Amyloidosis was diagnosed and followed up in KCMH since 2000 3. At least one of following investigations suspected amyloidosis (1) ECG, (2) Echocardiography, (3) Cardiac MRI 4. At least one of following investigations compatible with amyloidosis (1) Pathological finding demonstrate amyloid fibrils, (2) 99mTc-PYP uptake compatible with cardiac amyloidosis

Exclusion criteria

Exclusion criteria: None of investigation (ECG, Echocardiography, cardiac MRI) demonstrate the suspected cardiac amyloidosis

Design outcomes

Primary

Measure	Time frame
Death time since diagnosis death rate	—

Secondary

Measure	Time frame
Cardiac arrhythmia time after diagnosis event rate,Coronary artery disease time after diagnosis Event rate,Heart failure hospitalization time after diagnosis event rate,Medication time after diagnosis dosage	—

Countries

Thailand

Contacts

Public ContactPatchara Kochaiyapatana

King Chulalongkorn Memorial Hospital

nick_patch@hotmail.com0841066685

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026